CERASORB® M as a Graft Extender in Orthopedic and Spine Surgery

Written by: Dr. Sneha Dhanke

Expanding Graft Volume While Supporting Predictable Bone Regeneration

With more than 2 million bone grafting procedures performed annually worldwide, surgeons face a persistent constraint: limited autograft volume.ⁱ Donor-site morbidity and restricted supply have made graft extenders an essential component of modern orthopedic and spine surgery.

Autologous bone graft remains the gold standard due to its osteogenic, osteoinductive, and osteoconductive properties. However, in routine clinical practice, its use is frequently limited by availability and harvest-related morbidity. Iliac crest harvesting, in particular, is associated with increased operative time, postoperative pain, and potential complications.^ii,iii

According to Wang et al. and Plantz et al., these limitations significantly influence surgical decision-making and have led to the routine incorporation of graft extenders.^iii,iv

“In many cases, the decision to use a graft extender is not optional; it is driven by the practical limitations of autograft availability and morbidity.”

Graft extenders enable surgeons to expand graft volume while maintaining an osteoconductive environment for bone regeneration.ⁱⁱ

According to Plantz et al., they are increasingly used to minimize autograft harvest requirements, particularly in fusion procedures, without compromising outcomes.^iv

“Graft extenders are a practical tool to reduce iliac crest harvesting while maintaining sufficient graft volume for fusion or defect filling.”

This shift has positioned synthetic bone graft substitutes, particularly β-tricalcium phosphate (β-TCP), as key components in modern bone reconstruction strategies.^ii,iii

The Role of a Graft Extender

In both orthopedic and spine procedures, available autograft is often insufficient to fill larger defects or fusion beds. Graft extenders address this limitation by providing a scaffold for bone ingrowth while increasing total graft volume.^v,ii

An effective graft extender should provide:

• Osteoconductive support
• Controlled and predictable resorption
• Interconnected porosity for vascularization
• Reliable intraoperative handling

CERASORB^® M: Designed for Predictable Bone Remodeling

CERASORB^® M is a phase-pure (>99%) β-tricalcium phosphate bone graft substitute developed to function as a reliable graft extender.

Its interconnected multi-porosity structure supports:

The material undergoes osteoclast-mediated resorption, allowing gradual replacement with newly formed bone, consistent with established principles of bone remodeling.^iii,ii

For surgeons, this provides a graft extender that integrates biologically while maintaining predictable resorption kinetics.

Orthopedic and Spine Applications

CERACELL^® Foam + CERASORB^® M

In both orthopedic and spine surgery, successful bone regeneration depends on creating a stable, biologically active environment that supports vascularization, cellular activity, and new bone formation.

Whether managing bone defects in orthopedic reconstruction or achieving solid arthrodesis in spine surgery, surgeons are frequently limited by insufficient autograft volume. As a result, graft extenders are routinely used to expand graft constructs while maintaining biological performance.

Clinical Use Cases

Combined Approach

This combination supports consistent graft distribution and biological integration, both essential for successful fusion.

Biological Integration

CERASORB^® M supports bone regeneration through a physiological remodeling process:

1. Blood infiltrates the porous scaffold
2. Osteogenic cells migrate into the structure
3. New bone forms along the β-TCP surface
4. The material is gradually resorbed
5. Native bone replaces the scaffold

This coupled process of resorption and bone formation reflects well-established biological principles of bone healing.^ii,iii

Supporting Surgical Efficiency

Beyond biological performance, graft materials must integrate efficiently into surgical workflow.

CERASORB^® M offers:

1. A synthetic, safe alternative with no disease transmission riskⁱⁱ
2. Consistent handling characteristics
3. Controlled resorption behavior
4. Expanded graft volume with reduced autograft dependency^iv

These characteristics allow surgeons to optimize graft constructs while minimizing additional morbidity.

Conclusion

As orthopedic and spine procedures continue to increase in complexity, the use of graft extenders has become standard practice.

By addressing the limitations of autograft and supporting predictable bone regeneration, CERASORB^® M, in combination with CERACELL^® Foam, enables:

• Expanded graft volume
• Reliable osteoconductive support
• Adaptation to complex defect environments
• Predictable remodeling into native bone

For surgeons, this represents a practical, scalable, and biologically sound approach to modern bone reconstruction.

---

[i] https://www.towardshealthcare.com/insights/bone-grafts-and-substitutes-market-sizing

[ii] Sohn, HS., Oh, JK. Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomater Res 23, 9 (2019). https://doi.org/10.1186/s40824-019-0157-y

[iii] Wang W, Yeung KWK. Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioactive Materials. 2017 Dec;2(4):224-247. DOI: 10.1016/j.bioactmat.2017.05.007. PMID: 29744432; PMCID: PMC5935655.

[iv] Synthetic Bone Graft Materials in Spine Fusion: Current Evidence and Future Trends. Mark A. Plantz Erik B. Gerlach and Wellington K. Hsu. International Journal of Spine Surgery Apr 2021, 15 (s1) 104- 112; DOI: 10.14444/8058

[v] Calori, G. M., Mazza, E., Colombo, M., & Ripamonti, C. (2011). The use of bone-graft substitutes in large bone defects: any specific needs?. Injury, 42, S56-S63.